These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Chiang AK; Tao Q; Srivastava G; Ho FC Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467 [TBL] [Abstract][Full Text] [Related]
32. Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts. Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Wang S; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ Orphanet J Rare Dis; 2014 Dec; 9():165. PubMed ID: 25475054 [TBL] [Abstract][Full Text] [Related]
33. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell. Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744 [TBL] [Abstract][Full Text] [Related]
34. Progress in understanding and managing natural killer-cell malignancies. Oshimi K Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type. Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105 [TBL] [Abstract][Full Text] [Related]
36. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients. Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282 [TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma. Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590 [TBL] [Abstract][Full Text] [Related]
38. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K; Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368 [TBL] [Abstract][Full Text] [Related]
39. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults. RodrÃguez-Pinilla SM; Barrionuevo C; Garcia J; MartÃnez MT; Pajares R; Montes-Moreno S; Casavilca S; Montes J; Bravo F; Zaharia M; Zevallos-Giampietri E; Sanchez L; Piris MA Am J Surg Pathol; 2010 Dec; 34(12):1773-82. PubMed ID: 21107082 [TBL] [Abstract][Full Text] [Related]